Bank of New York Mellon Corp - TRANSENTERIX INC ownership

TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 131 filers reported holding TRANSENTERIX INC in Q3 2019. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TRANSENTERIX INC
ValueSharesWeighting
Q3 2019$477,000
-55.7%
769,315
-2.8%
0.00%
Q2 2019$1,076,000
-37.6%
791,204
+9.1%
0.00%
Q1 2019$1,725,000
+2.9%
724,889
-2.3%
0.00%
-100.0%
Q4 2018$1,677,000
-46.7%
741,871
+36.6%
0.00%0.0%
Q3 2018$3,149,000
+43.7%
543,078
+8.0%
0.00%0.0%
Q2 2018$2,192,000
+763.0%
502,630
+236.7%
0.00%
Q1 2018$254,000
+10.0%
149,275
+24.8%
0.00%
Q4 2017$231,000
+162.5%
119,584
+94.0%
0.00%
Q3 2017$88,000
+91.3%
61,640
-5.0%
0.00%
Q2 2017$46,000
-90.0%
64,865
-83.0%
0.00%
Q1 2017$461,000
+3.6%
380,504
+11.1%
0.00%
Q4 2016$445,000
-9.0%
342,371
+18.4%
0.00%
Q3 2016$489,000
+49.5%
289,231
+7.9%
0.00%
Q2 2016$327,000
-61.6%
268,087
+34.0%
0.00%
Q1 2016$851,000
+117.6%
200,119
+26.9%
0.00%
Q4 2015$391,000
-23.2%
157,688
-29.9%
0.00%
Q3 2015$509,000
+45.4%
225,009
+92.6%
0.00%
Q2 2015$350,000
+2.3%
116,839
+0.0%
0.00%
Q1 2015$342,0000.0%116,808
-0.7%
0.00%
Q4 2014$342,000
-35.2%
117,588
-3.0%
0.00%
Q3 2014$528,000
-53.0%
121,207
-45.7%
0.00%
Q2 2014$1,124,000223,2940.00%
Other shareholders
TRANSENTERIX INC shareholders Q3 2019
NameSharesValueWeighting ↓
SV Health Investors, LLC 7,546,692$10,792,0008.18%
StepStone Group LP 3,032,625$4,336,0002.87%
Aisling Capital LLC 10,335,819$14,780,0002.43%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 889,082$1,271,0000.50%
ELEMENT CAPITAL MANAGEMENT LLC 249,959$357,0000.15%
MASTERS CAPITAL MANAGEMENT LLC 4,000,000$5,720,0000.13%
BRANDYWINE MANAGERS, LLC 49,000$70,0000.02%
NATIONAL PLANNING CORP 159,250$228,0000.02%
Jacobi Capital Management LLC 30,000$45,0000.02%
AE Wealth Management LLC 106,010$152,0000.01%
View complete list of TRANSENTERIX INC shareholders